The previous studies demonstrated that EPCAM overexpression was an independent unfavorable prognostic factor and was linked with larger tumor size and lymph node metastasis in GC patients (Chen et al., 2016; Dai et al., 2017). Here, EPCAM is linked to gastric cancer.